ZYIL1
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ZYIL1, covering 2022-07-11 to 2024-12-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates [Phase 2]